| Therapeutic ID93 + GLA-SE Vaccination in Participants With Rifampicin-Susceptible Pulmonary TB (NCT06205589) | Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections | 2026-07-01 |
| Menopausal HT for Women Living With HIV (HoT) (NCT06856174) | Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections | 2026-04-09 |
| Antiretrovirals Combined With Antibodies for HIV-1 Cure In Africa (NCT06205602) | Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections | 2025-01-17 |
| Pausing Antiretroviral Treatment Under Structured Evaluation (NCT06031272) | Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections | 2024-05-28 |
| Observational PIC Destination Cohort (NCT05985642) | Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections | 2024-03-19 |
| Pharmacokinetic Interactions of ENG Subdermal Implants with Long-Acting Cabotegravir (CAB-LA) and LA Rilpivirine (RPV-LA) (CARLA) (NCT05156658) | Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections | 2024-01-01 |
| Doravirine for Obese Persons on Integrase Inhibitors and Tenofovir Alafenamide (NCT04636437) | Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections | 2021-07-27 |
| Glecaprevir/Pibrentasvir Fixed-dose Combination Treatment for Acute Hepatitis C Virus Infection (NCT04042740) | Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections | 2019-11-20 |
| Assess Therapeutic Efficacy and Emergence of HIV Drug Resistance Following Initiation of TLD (NCT04050449) | Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections | 2019-10-28 |
| Pharmacokinetic Study to Evaluate Double-Dose Levonorgestrel Emergency Contraception in Combination With Efavirenz-Based Antiretroviral Therapy or Rifampicin-Containing Anti-Tuberculosis Therapy (NCT03819114) | Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections | 2019-05-06 |
| Monitoring SOF/VEL in Treatment Naïve, HCV Participants With Active Infection (NCT03512210) | Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections | 2018-10-22 |
| PREPARE (A5361s) Ancillary Study of REPRIEVE (A5332) (NCT03070223) | Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections | 2017-03-14 |
| Biomarkers to Predict Time to Plasma HIV RNA Rebound (NCT03001128) | Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections | 2017-02-23 |
| Early ART to Limit Infection and Establishment of Reservoir (NCT02859558) | Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections | 2017-01-24 |
| Effects of the Probiotic Visbiome Extra Strength on Gut Microbiome & Immune Activation Markers (NCT02706717) | Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections | 2016-04-01 |
| 12 Weeks of Ledipasvir (LDV)/Sofosbuvir (SOF) With Weight-based Ribavirin vs. 24 Weeks of LDV/SOF (NCT02605304) | Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections | 2016-02-17 |
| Safety and Efficacy of Sirolimus for HIV Reservoir Reduction in Individuals on Suppressive Antiretroviral Therapy (ART) (NCT02440789) | Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections | 2015-12-21 |
| Dolutegravir Plus Lamivudine Dual Therapy in Treatment Naïve HIV-1 Patients (NCT02582684) | Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections | 2015-12-08 |
| PK Study of Rifampicin Interactions With DMPA and Efavirenz in TB (NCT02412436) | Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections | 2015-11-03 |
| Sitagliptin for Reducing Inflammation and Immune Activation (NCT02513771) | Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections | 2015-09-01 |
| Essentiality of INH in TB Therapy (NCT01589497) | Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections | 2015-06-30 |
| Evaluating Pharmacokinetic Interactions With Vaginal Ring Contraceptives and ART (NCT01903031) | Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections | 2014-12-30 |
| High-Dose Isoniazid Among Adult Patients With Different Genetic Variants of INH-Resistant Tuberculosis (TB) (NCT01936831) | Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections | 2014-08-13 |
| Modulation of Immune Activation by Aspirin (NCT02155985) | Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections | 2014-08-01 |
| Effect of Isotretinoin on Immune Activation Among HIV-1 Infected Subjects With Incomplete CD4+ T Cell Recovery (NCT01969058) | Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections | 2014-07-02 |
| Sofosbuvir-Containing Regimens Without Interferon For Treatment of Acute Hepatitis C Virus (HCV) Infection (NCT02128217) | Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections | 2014-05-30 |
| Comparing PI-Based to a nNRTI-based ART for Clearance of Plasmodium Falciparum Parasitemia in HIV-Infected (NCT01632891) | Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections | 2014-01-10 |
| Telmisartan to Reduce AIDS-Related Fibrotic and Inflammatory Contributors (TRAFIC Study) (NCT01928927) | Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections | 2014-01-01 |
| Three Chemo Regimens as an Adjunct to ART for Treatment of Advanced AIDS-KS (NCT01435018) | Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections | 2013-10-01 |
| Rifampin-Based Tuberculosis Treatment Versus Rifabutin-Based Tuberculosis Treatment in Persons With HIV (NCT01601626) | Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections | 2013-07-13 |
| FTC/RPV/TDF on T-Cell Activation, CD4+ T-Cell Count, Inflammatory Biomarkers and Viral Reservoir (NCT01777997) | Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections | 2013-04-25 |
| A5288/MULTI-OCTAVE: Management Using Latest Technologies to Optimize Combination Therapy After Viral Failure (NCT01641367) | Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections | 2013-02-22 |
| HPV Test-and-Treat-Strategy Versus Cytology-based Strategy for Prevention of CIN2+ in HIV-Infected Women (NCT01315353) | Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections | 2012-04-04 |
| Study of Options for Second-Line Effective Combination Therapy (SELECT) (NCT01352715) | Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections | 2012-03-13 |
| Bone, Immunologic, and Virologic Effects of a Antiretroviral Regimen (NCT01400412) | Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections | 2012-01-17 |
| Antiretroviral Therapy (ART) Alone or With Delayed Chemo Versus ART With Immediate Chemo for Limited AIDS-related Kaposi's Sarcoma (NCT01352117) | Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections | 2011-11-18 |
| Sevelamer for Reducing Endotoxemia and Immune Activation (NCT01543958) | Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections | 2011-11-01 |
| Effect of HAART Vs. Statin Treatment on Endothelial Function and Inflammation/Coagulation (NCT01515813) | Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections | 2011-11-01 |
| Endothelial Function, Lipoproteins, and Inflammation With Low HDL Cholesterol in HIV: ER Niacin Versus Fenofibrate (NCT01426438) | Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections | 2011-11-01 |
| REMEMBER: Reducing Early Mortality & Morbidity by Empiric Tuberculosis (TB) Treatment (NCT01380080) | Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections | 2011-10-01 |
| High Dose Vitamin D and Calcium for Bone Health in Individuals Initiating HAART (NCT01403051) | Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections | 2011-09-01 |
| Rifaximin as a Modulator of Microbial Translocation and Immune Activation (NCT01466595) | Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections | 2011-09-01 |
| Gentian Violet Vs. Nystatin Oral Suspension for Treatment of Oropharyngeal Candidiasis (NCT01427738) | Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections | 2011-06-01 |
| Pharmacokinetic Interactions Between DMPA and LPV/r Among HIV-Infected Women (NCT01296152) | Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections | 2011-05-01 |
| Atorvastatin on Biomarkers of Inflammation, Coagulopathy, Angiogenesis & T-cells (NCT01351025) | Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections | 2011-04-14 |
| Telephone Support to Improve Adherence to Anti-HIV Medications (NCT00988442) | Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections | 2010-10-01 |
| Examining the Incidence of Oral Human Papillomavirus (HPV) Shedding and Oral Warts After Beginning HAART in HIV-Infected Adults (NCT01029249) | Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections | 2010-01-01 |
| Durability of Adherence in Self-Management of HIV (NCT00991302) | Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections | 2010-01-01 |
| Observational Study of Specificity of Mycobacterium Tuberculosis Screening and Diagnostics in HIV-Infected Individuals (NCT00865826) | Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections | 2009-12-01 |
| Assessing HIV-Related Oral Mucosal Disease and Using Saliva to Measure Viral Load (NCT00959413) | Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections | 2009-09-01 |
| Faster Identification of TB and Evaluation of Drug Resistance in HIV-infected People (NCT00959088) | Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections | 2009-08-01 |
| Impact of Antiretroviral Therapy on Metabolic, Skeletal, and Cardiovascular Parameters (NCT00851799) | Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections | 2009-06-01 |
| Comparative Study of Three NNRTI-Sparing HAART Regimens (NCT00811954) | Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections | 2009-05-01 |
| Safety and Effectiveness of Raltegravir Plus Darunavir/Ritonavir in Treatment-Naive HIV-Infected Adults (NCT00830804) | Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections | 2009-04-01 |
| Determining the Effects of Observed and Self-Administered Drug Regimens in HIV Infected Adults (NCT00608569) | Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections | 2009-03-01 |
| Pioglitazone Before Peginterferon and Ribavirin for Hepatitis C Infection in HIV/HCV-Coinfected Patients With Insulin Resistance (NCT00665353) | Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections | 2009-03-01 |
| Chloroquine for Reducing Immune Activation in HIV- Infected Individuals (NCT00819390) | Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections | 2009-03-01 |
| Adding Maraviroc to Antiretroviral Therapy for Suboptimal CD4 T-Cell Recovery Despite Sustained Virologic Suppression (NCT00709111) | Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections | 2009-01-01 |
| Safety and Effectiveness of Lopinavir/Ritonavir in Individuals Who Have Failed Prior HIV Therapy (NCT00357552) | Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections | 2008-01-01 |
| HIV Treatment Reinitiation in Women Who Received Anti-HIV Drugs to Prevent Mother-to-Child Transmission of HIV (NCT00442962) | Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections | 2007-05-01 |
| Minocycline for the Treatment of Decreased Mental Function in HIV-Infected Adults (NCT00361257) | Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections | 2007-03-01 |
| NNRTI vs PI Regimens for HIV Infected Women After They Have Taken Nevirapine to Prevent Mother-To-Child HIV Transmission (NCT00089505) | Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections | 2006-11-01 |
| Immediate Versus Deferred Start of Anti-HIV Therapy in HIV-Infected Adults Being Treated for Tuberculosis (NCT00108862) | Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections | 2006-08-01 |
| Effects of Maternal Anti-HIV Treatment on Infants Born to HIV-Infected Women (NCT00100867) | Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections | 2006-06-01 |
| A Study of Dementia and Neurological Problems in HIV Infected Patients Who Are Participating in ACTG A5175 (NCT00096824) | Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections | 2006-02-01 |
| Efavirenz or Atazanavir/Ritonavir Given With Emtricitabine/Tenofovir Disoproxil Fumarate or Abacavir/Lamivudine in HIV Infected Treatment-Naive Adults (NCT00118898) | Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections | 2005-09-01 |
| Prospective Evaluation of Anti-retroviral Combinations for Treatment Naive, HIV Infected Persons in Resource-limited Settings (NCT00084136) | Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections | 2005-05-01 |
| Nine Month Course of Anti-HIV Medications for People Recently Infected With HIV (NCT00090779) | Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections | 2005-01-01 |
| Consent for Use of Stored Patient Specimens for Future Testing (NCT00031408) | Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections | 2002-02-13 |
| Long-Term Data Collection From Participants in Adult AIDS Clinical Trials (NCT00001137) | Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections | 2000-01-01 |